Market Tracker

09/22 3:43am ET

Arbutus Biopharma Corp (NASDAQ:ABUS)

7.00
Delayed Data
As of Sep 21
 +0.30 / +4.48%
Today’s Change
2.35
Today|||52-Week Range
7.85
+185.71%
Year-to-Date

Today’s Trading

Previous close6.70
Today’s open7.20
Day’s range6.75 - 7.20
Volume1,530,814
Average volume (3 months)193,353
Market cap$368.7M
Dividend yield--
Data as of 4:00pm ET, 09/21/2017

Growth & Valuation

Earnings growth (last year)-440.30%
Earnings growth (this year)+79.90%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-94.01%
P/E ratio--
Price/Sales87.21
Price/Book1.81

Competitors

 Today’s
change
Today’s
% change
ARDXArdelyx Inc-0.05-0.92%
DRRXDURECT Corp+0.04+2.42%
CPRXCatalyst Pharmaceuti...+0.01+0.41%
PETXAratana Therapeutics...-0.12-2.00%
Data as of 4:00pm ET, 09/21/2017

Financials

Next reporting dateNovember 3, 2017
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$1.5M
Annual profit (last year)-$384.2M
Net profit margin-25,765.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer &
Executive Vice President
Bruce G. Cousins
Corporate headquarters
Burnaby, British Columbia

Forecasts